Medical Technology

Current search: " boehringer ingelheim "

@xconomy.com 3 years ago

Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More

@xconomy.com 3 years ago

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

@xconomy.com 4 years ago

FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes

@xconomy.com 4 years ago

Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More

@xconomy.com 4 years ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 4 years ago

Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer

@xconomy.com 5 years ago

ResMed Boosts Connected Health Play With $225M Propeller Health Deal

@xconomy.com 5 years ago

Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More

@xconomy.com 5 years ago

Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M

@xconomy.com 5 years ago

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines